420 related articles for article (PubMed ID: 22832853)
1. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder.
Frodl T; Carballedo A; Hughes MM; Saleh K; Fagan A; Skokauskas N; McLoughlin DM; Meaney J; O'Keane V; Connor TJ
Transl Psychiatry; 2012 Mar; 2(3):e88. PubMed ID: 22832853
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder.
Frodl T; Carballedo A; Frey EM; O'Keane V; Skokauskas N; Morris D; Gill M; Hughes MM; Harkin A; Connor T
Dev Psychopathol; 2014 Nov; 26(4 Pt 2):1209-17. PubMed ID: 25422956
[TBL] [Abstract][Full Text] [Related]
3. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal atrophy in major depression: a function of childhood maltreatment rather than diagnosis?
Opel N; Redlich R; Zwanzger P; Grotegerd D; Arolt V; Heindel W; Konrad C; Kugel H; Dannlowski U
Neuropsychopharmacology; 2014 Nov; 39(12):2723-31. PubMed ID: 24924799
[TBL] [Abstract][Full Text] [Related]
5. Effects of early life adversity and FKBP5 genotype on hippocampal subfields volume in major depression.
Mikolas P; Tozzi L; Doolin K; Farrell C; O'Keane V; Frodl T
J Affect Disord; 2019 Jun; 252():152-159. PubMed ID: 30986730
[TBL] [Abstract][Full Text] [Related]
6. Effects of childhood adversity on the volumes of the amygdala subnuclei and hippocampal subfields in individuals with major depressive disorder.
Aghamohammadi-Sereshki A; Coupland NJ; Silverstone PH; Huang Y; Hegadoren KM; Carter R; Seres P; Malykhin NV
J Psychiatry Neurosci; 2021 Jan; 46(1):E186-E195. PubMed ID: 33497169
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder.
Klok MD; Alt SR; Irurzun Lafitte AJ; Turner JD; Lakke EA; Huitinga I; Muller CP; Zitman FG; de Kloet ER; Derijk RH
J Psychiatr Res; 2011 Jul; 45(7):871-8. PubMed ID: 21195417
[TBL] [Abstract][Full Text] [Related]
8. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
[TBL] [Abstract][Full Text] [Related]
9. Association between glucocorticoid receptor methylation and hippocampal subfields in major depressive disorder.
Na KS; Chang HS; Won E; Han KM; Choi S; Tae WS; Yoon HK; Kim YK; Joe SH; Jung IK; Lee MS; Ham BJ
PLoS One; 2014; 9(1):e85425. PubMed ID: 24465557
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in blood of children and adolescents: Mediation between childhood maltreatment and major depressive disorder.
Spindola LM; Pan PM; Moretti PN; Ota VK; Santoro ML; Cogo-Moreira H; Gadelha A; Salum G; Manfro GG; Mari JJ; Brentani H; Grassi-Oliveira R; Brietzke E; Miguel EC; Rohde LA; Sato JR; Bressan RA; Belangero SI
J Psychiatr Res; 2017 Sep; 92():24-30. PubMed ID: 28384542
[TBL] [Abstract][Full Text] [Related]
11. Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report.
Mazurka R; Cunningham S; Hassel S; Foster JA; Nogovitsyn N; Fiori LM; Strother SC; Arnott SR; Frey BN; Lam RW; MacQueen GM; Milev RV; Rotzinger S; Turecki G; Kennedy SH; Harkness KL
Eur Neuropsychopharmacol; 2024 Jan; 78():71-80. PubMed ID: 38128154
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed.
Alt SR; Turner JD; Klok MD; Meijer OC; Lakke EA; Derijk RH; Muller CP
Psychoneuroendocrinology; 2010 May; 35(4):544-56. PubMed ID: 19782477
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid effects in the kidney: correlation between alphaENaC, GILZ, and Sgk-1 mRNA expression and urinary excretion of Na+ and K+.
Muller OG; Parnova RG; Centeno G; Rossier BC; Firsov D; Horisberger JD
J Am Soc Nephrol; 2003 May; 14(5):1107-15. PubMed ID: 12707381
[TBL] [Abstract][Full Text] [Related]
14. Amygdala and hippocampal volumes in familial early onset major depressive disorder.
MacMaster FP; Mirza Y; Szeszko PR; Kmiecik LE; Easter PC; Taormina SP; Lynch M; Rose M; Moore GJ; Rosenberg DR
Biol Psychiatry; 2008 Feb; 63(4):385-90. PubMed ID: 17640621
[TBL] [Abstract][Full Text] [Related]
15. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.
Anacker C; Cattaneo A; Musaelyan K; Zunszain PA; Horowitz M; Molteni R; Luoni A; Calabrese F; Tansey K; Gennarelli M; Thuret S; Price J; Uher R; Riva MA; Pariante CM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8708-13. PubMed ID: 23650397
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal neuroplasticity in major depressive disorder.
Malykhin NV; Coupland NJ
Neuroscience; 2015 Nov; 309():200-13. PubMed ID: 25934030
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal subfield analysis in medication-naïve female patients with major depressive disorder.
Han KM; Won E; Sim Y; Tae WS
J Affect Disord; 2016 Apr; 194():21-9. PubMed ID: 26802503
[TBL] [Abstract][Full Text] [Related]
18. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
[TBL] [Abstract][Full Text] [Related]
19. Effects of cortisol on hippocampal subfields volumes and memory performance in healthy control subjects and patients with major depressive disorder.
Travis SG; Coupland NJ; Hegadoren K; Silverstone PH; Huang Y; Carter R; Fujiwara E; Seres P; Malykhin NV
J Affect Disord; 2016 Sep; 201():34-41. PubMed ID: 27162154
[TBL] [Abstract][Full Text] [Related]
20. Childhood maltreatment and psychopathology affect brain development during adolescence.
Whittle S; Dennison M; Vijayakumar N; Simmons JG; Yücel M; Lubman DI; Pantelis C; Allen NB
J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):940-952.e1. PubMed ID: 23972696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
